1. Phytochemicals: Potential Lead Molecules for MDR Reversal
   Boshra Tinoush et al, 2020, Frontiers in Pharmacology CrossRef
2. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors
   Changwei Liu et al, 2019, Molecules CrossRef
3. Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells
   Yan Wen et al, 2017, Oncotarget CrossRef
4. Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: From bench to bedside
   Bing Hu, 2015, World Journal of Hepatology CrossRef
5. Camellia sinensis: Insights on its molecular mechanisms of action towards nutraceutical, anticancer potential and other therapeutic applications
   Priya Chaudhary et al, 2023, Arabian Journal of Chemistry CrossRef
6. The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases
   Sha Li et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef
7. PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy
   Yanping Li et al, 2019, Frontiers in Pharmacology CrossRef
8. Targeting Tumor Cells with Nanoparticles for Enhanced Co-Drug Delivery in Cancer Treatment
   Wen-Ying Huang et al, 2021, Pharmaceutics CrossRef
9. Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy
   José M. Estrela et al, 2017, Journal of Medicinal Chemistry CrossRef
10. The role of catechin in electroporation of pancreatic cancer cells – Effects on pore formation and multidrug resistance proteins
    Olga Michel et al, 2022, Bioelectrochemistry CrossRef
11. Active Tumor-Targeted co-Delivery of Epigallocatechin Gallate and Doxorubicin in Nanoparticles for Combination Gastric Cancer Therapy
    Fwu-Long Mi et al, 2018, ACS Biomaterials Science & Engineering CrossRef